Clinical trial
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent…
NCT00338351 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00338351 |
|---|---|
| Title | Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine. |
| Official title | To Assess Reactogenicity and Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine, When Co-administered With GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine (Infanrix™ Hexa) at 2, 4 and 6 Months of Age. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis A |
| Intervention type | Biological |
| Interventions | Pneumococcal (vaccine) |
| Enrollment | 240 |
| Start date | Apr 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Jun 20, 2006 |
| Last update posted | Sep 28, 2016 |
| Countries | Chile |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: